查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301039

美國臍帶血銀行服務市場規模、份額和趨勢分析報告：按銀行類型、組成部分、州、細分市場預測，2023-2030 年

U.S. Cord Blood Banking Services Market Size, Share & Trends Analysis Report By Bank Type, By Component (Cord Blood, Tissue, Placenta), By States (Texas, Arizona, California, Florida, Kentucky, New Jersey), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 105 Pages | 商品交期: 2-10個工作天內

價格

美國臍帶血銀行服務市場增長和趨勢

美國臍帶血銀行服務市場規模預計到 2030 年將達到 165.9 億美元，在市場估算和預測期內復合年增長率為 11.56%。

臍帶血是造血幹細胞的重要來源，可用於患有某些危及生命的疾病的兒童進行自體和同種異體移植。 同樣，臍帶血移植是治療某些血液惡性腫瘤、免疫缺陷、血紅蛋白病和代謝紊亂的一種有前途的治療方法。 此外，涉及從 CB 中提取健康 T 細胞用於基於免疫療法的癌症治療的研究已顯示出積極的結果。

這些研究表明，人們對使用 CB 治療慢性疾病越來越感興趣。 通過這種方式，我們正在推動市場的增長。 這種增長還歸因於CB和乾細胞在疾病治療中的使用不斷增加。 人們對商業銀行銀行業務優勢的認識不斷增強、服務提供商不斷擴大以及保險覆蓋範圍不斷擴大，預計將在預測期內進一步推動市場發展。 然而，高昂的存儲和託收成本以及私人銀行存儲單位無法使用的風險預計將在一定程度上限制市場增長。 COVID-19 大流行的經濟影響以及由此導致的消費者消費能力下降，導致使用 CB Bank 服務的家長人數減少。

大多數醫院仍然允許由經過培訓的專業人員收集 CB，但由於後勤限制、人員可用性有限、實施社交距離政策等，多種因素限制了 CB 銀行的創收活動對行業產生了負面影響。 此外，一些非營利組織正在努力提高人們對CB存儲的認識。 例如，2022 年 7 月，血液和生物製品促進協會 (AABB) 為此組織了多項活動，分享社交媒體圖片和補充資源，強調 CB 在幹細胞移植中的使用。 AABB Newsfeed 還強調了 CB 在各種研究應用中的使用。 這些努力可以提高人們對臍帶血庫的整體認識，並對市場增長產生積極影響。

美國臍帶血銀行服務市場報告亮點

  • 2022 年，私人銀行部門的銷售額佔比最高，因為私人銀行廣泛的客戶群可能歸因於比公共銀行更具吸引力的營銷策略。
  • 從組成部分來看，由於美國慢性病患病率上升和出生率上升，CB 細分市場將在 2022 年佔據市場主導地位。
  • 加利福尼亞州將在 2022 年佔據最大的銷售份額，並將在 2023 年至 2030 年期間以穩定的複合年增長率進一步擴大。
  • 其背景是該疾病的高患病率、大公司的存在、CB 在慢性病治療中的大量使用以及政府的支持性法規。

內容

第一章調查方法及範圍

  • 市場細分和範圍
  • 市場定義
  • 調查假設
  • 信息獲取
  • 信息或數據分析
  • 市場形成和驗證
  • 市場模式
  • 世界市場：CARG 計算
  • 目的

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第 3 章美國臍帶血銀行服務市場變量、趨勢和範圍

  • 市場體系展望
    • 母公司市場前景
    • 相關/補充市場前景
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
    • 市場挑戰
  • 從用戶角度分析
    • 消費者行為分析
    • 市場影響力分析
  • 美國臍帶血庫：市場分析工具
    • 行業分析 - 波特五力
    • 美國臍帶血庫 - 按因素（政治與法律、經濟與技術）進行 SWOT 分析
  • 按來源（自體和同種異體）使用臍帶血
    • 經批准的醫療條件
    • 潛在的醫療狀況
  • COVID-19 感染的影響分析

第四章銀行類型業務分析

  • 美國臍帶血銀行服務市場：2022 年和 2030 年銀行類型變化分析
  • 私人
  • 公開
  • 混合動力

第五章組件業務分析

  • 美國臍帶血銀行服務市場：2022 年和 2030 年成分變化分析
  • 臍帶血
  • 臍帶組織
  • 胎盤

第 6 章區域業務分析

  • 美國臍帶血銀行服務市場：區域差異分析
  • 亞利桑那州
    • 2018-2030 年亞利桑那州市場估算和預測
    • 亞利桑那州銀行類型展望
    • 亞利桑那州成分展望
  • 加利福尼亞州
    • 2018-2030 年加利福尼亞市場預估和預測
    • 加州銀行類型展望
    • 加州成分股展望
  • 佛羅裡達州
    • 2018-2030 年佛羅裡達市場預估和預測
    • 佛羅裡達銀行類型展望
    • 佛羅裡達成分展望
  • 肯塔基州
    • 2018-2030 年肯塔基州市場預估和預測
    • 肯塔基州銀行類型展望
    • 肯塔基州組件展望
  • 新澤西州
    • 2018-2030 年新澤西市場估算和預測
    • 新澤西州銀行類型展望
    • 新澤西州成分股展望
  • 德克薩斯州
    • 2018-2030 年德克薩斯州市場預估和預測
    • 德克薩斯州銀行類型展望
    • 德克薩斯州成分股展望
  • 馬薩諸塞州
    • 2018-2030 年馬薩諸塞州市場估算和預測
    • 馬薩諸塞州銀行類型展望
    • 馬薩諸塞州成分股前景

第 7 章：美國臍帶血銀行服務市場的競爭格局

  • 主要市場進入者的最新趨勢和影響分析
  • 公司分類
  • 供應商情況
  • 上市公司
    • 企業市場分析
    • 競爭儀表板分析
    • 協同分析：主要交易和戰略聯盟
  • 私人公司
    • 主要初創企業名單
    • 企業市場分析
  • 本地網絡地圖
  • 公司簡介
    • California Cryobank
    • Stemcyte Inc.
    • Cryo-Cell International, Inc.
    • Lifeforce Cryobank Sciences, Inc.
    • Stem Cell Cryobank Inc.
    • Norton Healthcare
    • Viacord
    • Miraclecord Inc.
    • New Jersey Cord Blood Bank
    • Carter Bloodcare
    • Cryocyte Llc
    • Americord Registry Llc
    • Maze Cord Blood
Product Code: GVR-2-68038-054-5

U.S. Cord Blood Banking Services Market Growth & Trends

The U.S. cord blood banking services market size is estimated to reach USD 16.59 billion by 2030, registering a CAGR of 11.56% during the forecast period, according to a new report by Grand View Research, Inc. Cord blood is a significant source of hematopoietic stem cells for autologous and allogeneic transplantation in children with certain fatal diseases. Similarly, CB transplantation represents a promising method for the treatment of certain hematologic malignancies, immunodeficiencies, hemoglobinopathies, and metabolic diseases. In addition, research studies involving the extraction of healthy T-cells from CB for use in immunotherapy-based cancer treatment have shown positive results.

Such studies indicate the rising focus on the use of CB for the treatment of chronic diseases. Thus, propelling the market growth. The growth can also be attributed to the increase in the use of CB & stem cells in disease treatment. Rising awareness about the benefits of CB banking, a growing range of service providers, and improving insurance coverage are likely to further drive the market during the forecast period. However, the high cost of storage & collection and the risk of non-usability of units stored with private banks are expected to limit the growth of the market to a certain extent. The impact of the COVID-19 pandemic on the economy and the resultant decrease in consumer spending power led to fewer parents using CB bank services.

Although the collection of CB by trained professionals was still allowed in most hospitals, several factors, such as logistical constraints, limited availability of staff, and implementation of social distancing policies, restricted the revenue generation activities for CB banks, which negatively affected the industry. Furthermore, several non-profit organizations are undertaking initiatives to raise awareness regarding the storage of CB. For instance, in July 2022, the Association for the Advancement of Blood & Biotherapies (AABB) organized several activities for this purpose and shared social media graphics and complementary resources highlighting CB usage in stem cell transplants. It also emphasized the use of CB in various research applications in the AABB Newsfeed. Such initiatives are boosting overall awareness about CB banking and can positively affect market growth.

U.S. Cord Blood Banking Services Market Report Highlights

  • In 2022, the private bank segment had the highest revenue share due to private banks' wide range of customers, potentially arise to their more enticing marketing strategies than public banks
  • By component, the CB segment dominated the market in 2022 due to the growing incidence of chronic diseases and the rise in the birth rate in the U.S.
  • California accounted for the largest revenue share in 2022 and will expand further at a steady CAGR from 2023 to 2030
  • This is due to the high prevalence of diseases, the presence of major companies, the high usage of CB for the treatment of chronic diseases, and supportive government regulations

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Market Definitions
    • 1.2.1 Information Analysis
    • 1.2.2 Market Formulation & Data Visualization
    • 1.2.3 Data Validation & Publishing
  • 1.3 Research Assumptions
  • 1.4 Information Procurement
    • 1.4.1 Primary Research
  • 1.5 Information Or Data Analysis
  • 1.6 Market Formulation & Validation
  • 1.7 Market Model
  • 1.8 Global Market: CARG Calculation
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 U.S. Cord Blood Banking Services Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Rising Applications Of Cord Blood For Treatment Of Various Disease Conditions
      • 3.2.1.2 Growing Awareness Regarding Cord Blood Treatments
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High Costs And Probability Of Nonusage
    • 3.2.3 Market Challenges
      • 3.2.3.1 Lack Of Donor Diversity
  • 3.3 User Perspective Analysis
    • 3.3.1 Consumer Behavior Analysis
    • 3.3.2 Market Influencer Analysis
  • 3.4 U.S. Cord Blood Banking: Market Analysis Tools
    • 3.4.1 Industry Analysis - Porter's Five Forces
    • 3.4.2 U.S. Cord Blood Banking - Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.5 Utilization Of Cord Blood By Origin (Autologous Vs. Allogenic)
    • 3.5.1 Approved Medical Conditions
    • 3.5.2 Potential Medical Conditions
  • 3.6 COVID-19 Impact Analysis

Chapter 4 Bank Type Business Analysis

  • 4.1 U.S. Cord Blood Banking Services Market: Bank Type Movement Analysis, 2022 & 2030
  • 4.2 Private
    • 4.2.1 U.S. Private Bank Type Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.3 Public
    • 4.3.1 U.S. Public Bank Type Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.4 Hybrid
    • 4.4.1 U.S. Hybrid Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Component Business Analysis

  • 5.1 U.S. Cord Blood Banking Services Market: Component Movement Analysis, 2022 & 2030
  • 5.2 Cord Blood
    • 5.2.1 U.S. Cord Blood Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.3 Cord Tissue
    • 5.3.1 U.S. Cord Tissue Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4 Placenta
    • 5.4.1 U.S. Placenta Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Regional Business Analysis

  • 6.1 U.S. Cord Blood Banking Services Market: Regional Movement Analysis
  • 6.2 Arizona
    • 6.2.1 Arizona Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2 Arizona Bank Type Outlook
      • 6.2.2.1 Private
      • 6.2.2.2 Public
      • 6.2.2.3 Hybrid
    • 6.2.3 Arizona Component Outlook
      • 6.2.3.1 Cord Blood
      • 6.2.3.2 Cord Tissue
      • 6.2.3.3 Placenta
  • 6.3 California
    • 6.3.1 California Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2 California Bank Type Outlook
      • 6.3.2.1 Private
      • 6.3.2.2 Public
      • 6.3.2.3 Hybrid
    • 6.3.3 California Component Outlook
      • 6.3.3.1 Cord Blood
      • 6.3.3.2 Cord Tissue
      • 6.3.3.3 Placenta
  • 6.4 Florida
    • 6.4.1 Florida Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2 Florida Bank Type Outlook
      • 6.4.2.1 Private
      • 6.4.2.2 Public
      • 6.4.2.3 Hybrid
    • 6.4.3 Florida Component Outlook
      • 6.4.3.1 Cord Blood
      • 6.4.3.2 Cord Tissue
      • 6.4.3.3 Placenta
  • 6.5 Kentucky
    • 6.5.1 Kentucky Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2 Kentucky Bank Type Outlook
      • 6.5.2.1 Private
      • 6.5.2.2 Public
      • 6.5.2.3 Hybrid
    • 6.5.3 Kentucky Component Outlook
      • 6.5.3.1 Cord Blood
      • 6.5.3.2 Cord Tissue
      • 6.5.3.3 Placenta
  • 6.6 New Jersey
    • 6.6.1 New Jersey Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2 New Jersey Bank Type Outlook
      • 6.6.2.1 Private
      • 6.6.2.2 Public
      • 6.6.2.3 Hybrid
    • 6.6.3 New Jersey Component Outlook
      • 6.6.3.1 Cord Blood
      • 6.6.3.2 Cord Tissue
      • 6.6.3.3 Placenta
  • 6.7 Texas
    • 6.7.1 Texas Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2 Texas Bank Type Outlook
      • 6.7.2.1 Private
      • 6.7.2.2 Public
      • 6.7.2.3 Hybrid
    • 6.7.3 Texas Component Outlook
      • 6.7.3.1 Cord Blood
      • 6.7.3.2 Cord Tissue
      • 6.7.3.3 Placenta
  • 6.8 Massachusetts
    • 6.8.1 Massachusetts Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2 Massachusetts Bank Type Outlook
      • 6.8.2.1 Private
      • 6.8.2.2 Public
      • 6.8.2.3 Hybrid
    • 6.8.3 Massachusetts Component Outlook
      • 6.8.3.1 Cord Blood
      • 6.8.3.2 Cord Tissue
      • 6.8.3.3 Placenta

Chapter 7 U.S. Cord Blood Banking Services Market Competitive Landscape

  • 7.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 7.2 Company Categorization
  • 7.3 Vendor Landscape
    • 7.3.1 List Of Key Distributors And Channel Partners
    • 7.3.2 Key Customers
  • 7.4 Public Companies
    • 7.4.1 Company Market Position Analysis
    • 7.4.2 Competitive Dashboard Analysis
    • 7.4.3 Synergy Analysis: Major Deals & Strategic Alliances
      • 7.4.3.1 Merger & Acquisition Deals
      • 7.4.3.2 Collaborations & Partnerships
      • 7.4.3.3 Business Expansion
  • 7.5 Private Companies
    • 7.5.1 List Of Key Emerging Companies
    • 7.5.2 Company Market Position Analysis
  • 7.6 Regional Network Map
  • 7.7 Company Profiles
    • 7.7.1 California Cryobank
      • 7.7.1.1 Company Overview
      • 7.7.1.2 Product Benchmarking
      • 7.7.1.3 Strategic Initiatives
    • 7.7.2 Stemcyte Inc.
      • 7.7.2.1 Company Overview
      • 7.7.2.2 Product Benchmarking
      • 7.7.2.3 Strategic Initiatives
    • 7.7.3 Cryo-Cell International, Inc.
      • 7.7.3.1 Company Overview
      • 7.7.3.2 Financial Performance
      • 7.7.3.3 Product Benchmarking
      • 7.7.3.4 Strategic Initiatives
    • 7.7.4 Lifeforce Cryobank Sciences, Inc.
      • 7.7.4.1 Company Overview
      • 7.7.4.2 Product Benchmarking
    • 7.7.5 Stem Cell Cryobank Inc.
      • 7.7.5.1 Company Overview
      • 7.7.5.2 Product Benchmarking
    • 7.7.6 Norton Healthcare
      • 7.7.6.1 Company Overview
      • 7.7.6.2 Product Benchmarking
    • 7.7.7 Viacord
      • 7.7.7.1 Company Overview
      • 7.7.7.2 Product Benchmarking
    • 7.7.8 Miraclecord Inc.
      • 7.7.8.1 Company Overview
      • 7.7.8.2 Product Benchmarking
    • 7.7.9 New Jersey Cord Blood Bank
      • 7.7.9.1 Company Overview
      • 7.7.9.2 Product Benchmarking
    • 7.7.10 Carter Bloodcare
      • 7.7.10.1 Company Overview
      • 7.7.10.2 Product Benchmarking
    • 7.7.11 Cryocyte Llc
      • 7.7.11.1 Company Overview
      • 7.7.11.2 Product Benchmarking
    • 7.7.12 Americord Registry Llc
      • 7.7.12.1 Company Overview
      • 7.7.12.2 Product Benchmarking
    • 7.7.13 Maze Cord Blood
      • 7.7.13.1 Company Overview
      • 7.7.13.2 Product Benchmarking

List of Tables

  • Table 1 List of secondary sources
  • Table 2 U.S. FDA-approved cord blood treatments
  • Table 3 Potential cord blood treatments
  • Table 4 List of key distributors and channel partners

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Volume price analysis
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Penetration & growth prospect mapping, by bank type
  • Fig. 13 Penetration & growth prospect mapping, by component
  • Fig. 14 U.S. cord blood banking services market driver impact
  • Fig. 15 U.S. cord blood banking services market restraint impact
  • Fig. 16 Porter's five force analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 U.S. cord blood banking services market: Bank type outlook & key takeaways
  • Fig. 19 U.S. cord blood banking services market: Bank type movement analysis
  • Fig. 20 U.S. private bank type market, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. public bank type market, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. hybrid market, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. cord blood banking services market: Component outlook & key takeaways
  • Fig. 24 U.S. cord blood banking services market: Component movement analysis
  • Fig. 25 U.S. cord blood market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. cord tissue market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. placenta market, 2018 - 2030 (USD Million)
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 U.S. cord blood banking services market: Regional movement analysis
  • Fig. 30 Arizona market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Arizona private bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Arizona public bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Arizona hybrid bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Arizona cord blood component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Arizona cord tissue component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Arizona placenta component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 California market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 California private bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 California public bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 California hybrid bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 California cord blood component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 California cord tissue component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 California placenta component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Florida market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Florida private bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Florida public bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Florida hybrid bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Florida cord blood component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Florida cord tissue component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Florida placenta component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Kentucky market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Kentucky private bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Kentucky public bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Kentucky hybrid bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Kentucky cord blood component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Kentucky cord tissue component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Kentucky placenta component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 New Jersey market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 New Jersey private bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 New Jersey public bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 New Jersey hybrid bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 New Jersey cord blood component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 New Jersey cord tissue component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 New Jersey placenta component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Texas market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Texas private bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Texas public bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Texas hybrid bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Texas cord blood component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Texas cord tissue component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Texas placenta component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Massachusetts market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Massachusetts private bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Massachusetts public bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Massachusetts hybrid bank type market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Massachusetts cord blood component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Massachusetts cord tissue component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Massachusetts placenta component market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 New developments-based initiatives by key market participants
  • Fig. 80 Participant categorization: U.S. cord blood banking services market
  • Fig. 81 Public company market position analysis, 2022
  • Fig. 82 Competitive dashboard analysis, by key market participants
  • Fig. 83 Private company market position analysis, 2022
  • Fig. 84 Regional network map